FNDC5 and type 2 diabetes mellitus: Moreover, the accretion of adiposity and obesity are metabolic disorders associated with reduced irisin secretion, and circulating levels of irisin are found to be particularly reduced in (non-metabolically healthy) obese patients with T2D [15,16].